1-2 of 2
Xufeng Luo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Clinical Trial of R-CHOP Combined with Lenalidomide in the First-Line Treatment for Patients with High Risk Diffuse Large B Cell Lymphoma

Shuang Zhao, Jiuyang Zhang, Zheng Yan, Yuanlin Xu, Zhihua Yao, Junfeng Chu, Shuna Yao, Haiying Wang, Wenping Zhou, Xufeng Luo, Peipei Zhang, Yanyan Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6237.
https://doi.org/10.1182/blood-2023-185955
Published: 2023
Journal Articles

Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN /PI3K signal pathway

Yonghui Li, Li Gao, Xufeng Luo, Lili Wang, Xiaoning Gao, Wei Wang, Junzhong Sun, Liping Dou, Jingxin Li, Chengwang Xu, Lixin Wang, Minhang Zhou, Mengmeng Jiang, Jihao Zhou, Michael A. Caligiuri, Clara Nervi, Clara D. Bloomfield, Guido Marcucci, Li Yu
Journal: Blood
Blood (2013) 121 (3): 499–509.
https://doi.org/10.1182/blood-2012-07-444729
Published: 2013
Includes: Supplemental data